Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind trial of selenium plus methimazole in Basedow's disease
2010-022840-19Phase 2Completed
- Sponsor
- University Medical Center Mainz
- Start
- Aug 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Graves' disease comparing Methimazole + selenium with Methimazole + placebo (2 arms). Primary endpoints: Response rate at week 24 and Relapse rate. Started Aug 2011; status: completed.
02
Drugs
selenium
03
Conditions
Graves' disease
Beyond the preview
Go deeper on 2010-022840-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022840-19.